Metabolism of albendazole, ricobendazole and flubendazole in Haemonchus contortus adults: Sex differences, resistance-related differences and the identification of new metabolites

. 2018 Apr ; 8 (1) : 50-58. [epub] 20180131

Jazyk angličtina Země Nizozemsko Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid29414106
Odkazy

PubMed 29414106
PubMed Central PMC6114105
DOI 10.1016/j.ijpddr.2018.01.005
PII: S2211-3207(17)30141-0
Knihovny.cz E-zdroje

Haemonchus contortus (family Trichostrongylidae, Nematoda), a hematophagous gastrointestinal parasite found in small ruminants, has a great ability to develop resistance to anthelmintic drugs. We studied the biotransformation of the three benzimidazole anthelmintics: albendazole (ABZ), ricobendazole (albendazole S-oxide; RCB) and flubendazole (FLU) in females and males of H. contortus in both a susceptible ISE strain and resistant IRE strain. The ex vivo cultivation of living nematodes in culture medium with or without the anthelmintics was used. Ultrasensitive UHPLC/MS/MS analysis revealed 9, 7 and 12 metabolites of ABZ, RCB and FLU, respectively, with most of these metabolites now described in the present study for the first time in H. contortus. The structure of certain metabolites shows the presence of biotransformation reactions not previously reported in nematodes. There were significant qualitative and semi-quantitative differences in the metabolites formed by male and female worms. In most cases, females metabolized drugs more extensively than males. Adults of the IRE strain were able to form many more metabolites of all the drugs than adults of the ISE strain. Some metabolites were even found only in adults of the IRE strain. These findings suggest that increased drug metabolism may play a role in resistance to benzimidazole drugs in H. contortus.

Zobrazit více v PubMed

Arguello-Garcia R., Cruz-Soto M., Gonzalez-Trejo R., Paz-Maldonado L.M.T., Bazan-Tejeda M.L., Mendoza-Hernandez G., Ortega-Pierres G. An antioxidant response is involved in resistance of Giardia duodenalis to albendazole. Front. Microbiol. 2015;6:286. PubMed PMC

Bartikova H., Skalova L., Lamka J., Szotakova B., Varady M. The effects of flubendazole and its metabolites on the larval development of Haemonchus contortus (Nematoda: Trichostrongylidae): an in vitro study. Helminthologia. 2010;47:269–272.

Brophy P.M., Mackintosh N., Morphew R.M. Anthelmintic metabolism in parasitic helminths: proteomic insights. Parasitology. 2012;139:1205–1217. PubMed

Chaudhry U., Redman E.M., Raman M., Gilleard J.S. Genetic evidence for the spread of a benzimidazole resistance mutation across southern India from a single origin in the parasitic nematode Haemonchus contortus. Int. J. Parasitol. 2015;45:721–728. PubMed

Choe K.P., Leung C.K., Miyamoto M.M. Unique structure and regulation of the nematode detoxification gene regulator, SKN-1: implications to understanding and controlling drug resistance. Drug Metab. Rev. 2012;44:209–223. PubMed PMC

Cvilink V., Skalova L., Szotakova B., Lamka J., Kostiainen R., Ketola R.A. LC-MS-MS identification of albendazole and flubendazole metabolites formed ex vivo by Haemonchus contortus. Anal. Bioanal. Chem. 2008;391:337–343. PubMed

Cvilink V., Szotakova B., Vokral I., Bartikova H., Lamka J., Skalova L. Liquid chromatography/mass spectrometric identification of benzimidazole anthelminthics metabolites formed ex vivo by Dicrocoelium dendriticum. Rapid Commun. Mass Spectr. 2009;23:2679–2684. PubMed

Fernando L., Furtado V., Bello A., Rabelo E.M.L. Benzimidazole resistance in helminths: from problem to diagnosis. Acta Trop. 2016;162:95–102. PubMed

Geary T.G. Are new anthelmintics needed to eliminate human helminthiases? Curr. Opin. Infect. Dis. 2012;25:709–717. PubMed

Howard J.T., O'Nan A.T., Maltecca C., Baynes R.E., Ashwell M.S. Differential gene expression across breed and sex in commercial pigs administered fenbendazole and flunixin meglumine. PLoS One. 2015;10 PubMed PMC

Igboeli O.O., Burka J.F., Fast M.D. Sea lice population and sex differences in P-glycoprotein expression and emamectin benzoate resistance on salmon farms in the Bay of Fundy, New Brunswick, Canada. Pest Manag. Sci. 2014;70:905–914. PubMed

Jones L.M., Flemming A.J., Urwin P.E. NHR-176 regulates cyp-35d1 to control hydroxylation-dependent metabolism of thiabendazole in Caenorhabditis elegans. Biochem. J. 2015;466:37–44. PubMed

Kaminsky R., Ducray P., Jung M., Clover R., Rufener L., Bouvier J., Weber S.S., Wenger A., Wieland-Berghausen S., Goebel T., Gauvry N., Pautrat F., Skripsky T., Froelich O., Komoin-Oka C., Westlund B., Sluder A., Maeser P. A new class of anthelmintics effective against drug-resistant nematodes. Nature. 2008;452 176–U119. PubMed

Kotze A.C., Prichard R.K. In: Anthelmintic resistance in Haemonchus contortus: history, mechanisms and diagnosis. Haemonchus contortus and haemonchosis - past, present and future trends. Gasser R.B., VonSamsonHimmelstjerna G., editors. vol. 93. 2016. pp. 397–428. PubMed

Laing S.T., Ivens A., Laing R., Ravikumar S., Butler V., Woods D.J., Gilleard J.S. Characterization of the xenobiotic response of Caenorhabditis elegans to the anthelmintic drug albendazole and the identification of novel drug glucoside metabolites. Biochem. J. 2010;432:505–514. PubMed

Lifschitz A., Lanusse C., Alvarez L. Host pharmacokinetics and drug accumulation of anthelmintics within target helminth parasites of ruminants. New Zealand Vet. J. 2017;65:176–184. PubMed

Lubega G.W., Prichard R.K. Specific interaction of benzimidazole anthelmintics with tubulin-high affinity binding and benzimidazole resistance in Haemonchus contortus. Mol. Biochem. Parasitol. 1990;38:221–232. PubMed

Lubega G.W., Prichard R.K. Beta-tubulin and benzimidazole resistance in the sheep nematode Haemonchus contortus. Mol. Biochem. Parasitol. 1991;47:129–137. PubMed

Matouskova P., Vokral I., Lamka J., Skalova L. The role of xenobiotic-metabolizing enzymes in anthelmintic deactivation and resistance in helminths. Trends Parasitol. 2016;32:481–491. PubMed

Podlipna R., Skalova L., Seidlova H., Szotakova B., Kubicek V., Stuchlikova L., Jirasko R., Vanek T., Vokral I. Biotransformation of benzimidazole anthelmintics in reed (Phragmites australis) as a potential tool for their detoxification in environment. Biores. Technol. 2013;144:216–224. PubMed

Raza A., Lamb J., Chambers M., Hunt P.W., Kotze A.C. Larval development assays reveal the presence of sub-populations showing high- and low-level resistance in a monepantel (Zolvix (R))-resistant isolate of Haemonchus contortus. Vet. Parasitol. 2016;220:77–82. PubMed

Raza A., Bagnall N.H., Jabbar A., Kopp S.R., Kotze A.C. Increased expression of ATP binding cassette transporter genes following exposure of Haemonchus contortus larvae to a high concentration of monepantel in vitro. Parasites Vectors. 2016;9:522. PubMed PMC

Redman E., Sargison N., Whitelaw F., Jackson F., Morrison A., Bartley D.J., Gilleard J.S. Introgression of ivermectin resistance genes into a susceptible Haemonchus contortus strain by multiple backcrossing. PLoS Pathog. 2012;8:e1002534. PubMed PMC

Roos M.H., Otsen M., Hoekstra R., Veenstra J.G., Lenstra J.A. Genetic analysis of inbreeding of two strains of the parasitic nematode Haemonchus contortus. Int. J. Parasitol. 2004;34:109–115. PubMed

Sales N., Love S. Resistance of Haemonchus sp to monepantel and reduced efficacy of a derquantel/abamectin combination confirmed in sheep in NSW, Australia. Vet. Parasitol. 2016;228:193–196. PubMed

Srivastava M., Misra-Bhattacharya S. Overcoming drug resistance for macro parasites. Future Microbiol. 2015;10:1783–1789. PubMed

Stuchlikova L., Jirasko R., Skalova L., Pavlik F., Szotakova B., Holcapek M., Vanek T., Podlipna R. Metabolic pathways of benzimidazole anthelmintics in harebell (Campanula rotundifolia) Chemosphere. 2016;157:10–17. PubMed

Stuchlikova L., Jirasko R., Vokral I., Lamka J., Spulak M., Holcapek M., Szotakova B., Bartikova H., Pour M., Skalova L. Investigation of the metabolism of monepantel in ovine hepatocytes by UHPLC/MS/MS. Anal. Bioanal. Chem. 2013;405:1705–1712. PubMed

Taman A., Azab M. Present-day anthelmintics and perspectives on future new targets. Parasitol. Res. 2014;113:2425–2433. PubMed

Vokral I., Bartikova H., Prchal L., Stuchlikova L., Skalova L., Szotakova B., Lamka J., Varady M., Kubicek V. The metabolism of flubendazole and the activities of selected biotransformation enzymes in Haemonchus contortus strains susceptible and resistant to anthelmintics. Parasitology. 2012;139:1309–1316. PubMed

Vokral I., Jirasko R., Stuchlikova L., Bartikova H., Szotakova B., Lamka J., Varady M., Skalova L. Biotransformation of albendazole and activities of selected detoxification enzymes in Haemonchus contortus strains susceptible and resistant to anthelmintics. Vet. Parasitol. 2013;196:373–381. PubMed

Waxman D.J., Holloway M.G. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol. Pharmacol. 2009;76:215–228. PubMed PMC

Yilmaz E., Ramunke S., Demeler J., Krucken J. Comparison of constitutive and thiabendazole-induced expression of five cytochrome P450 genes in fourth-stage larvae of Haemonchus contortus isolates with different drug susceptibility identifies one gene with high constitutive expression in a multi-resistant isolate. Int. J. Parasitol. Drug. Drug Resist. 2017;7:362–369. PubMed PMC

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Biotransformation of anthelmintics in nematodes in relation to drug resistance

. 2025 Jan 07 ; 27 () : 100579. [epub] 20250107

Phylogenetic and transcriptomic study of aldo-keto reductases in Haemonchus contortus and their inducibility by flubendazole

. 2024 Aug ; 25 () : 100555. [epub] 20240708

Flubendazole carbonyl reduction in drug-susceptible and drug-resistant strains of the parasitic nematode Haemonchus contortus: changes during the life cycle and possible inhibition

. 2024 Jan 15 ; 55 (1) : 7. [epub] 20240115

Short-chain dehydrogenases in Haemonchus contortus: changes during life cycle and in relation to drug-resistance

. 2023 Mar 07 ; 54 (1) : 19. [epub] 20230307

The induction and inhibition of UDP-glycosyltransferases in Haemonchus contortus and their role in the metabolism of albendazole

. 2022 Aug ; 19 () : 56-64. [epub] 20220616

Assessing the Anthelmintic Candidates BLK127 and HBK4 for Their Efficacy on Haemonchus contortus Adults and Eggs, and Their Hepatotoxicity and Biotransformation

. 2022 Mar 30 ; 14 (4) : . [epub] 20220330

Sertraline as a new potential anthelmintic against Haemonchus contortus: toxicity, efficacy, and biotransformation

. 2021 Dec 11 ; 52 (1) : 143. [epub] 20211211

The ATP bioluminescence assay: a new application and optimization for viability testing in the parasitic nematode Haemonchus contortus

. 2021 Sep 30 ; 52 (1) : 124. [epub] 20210930

UDP-Glycosyltransferases and Albendazole Metabolism in the Juvenile Stages of Haemonchus contortus

. 2020 ; 11 () : 594116. [epub] 20201126

Sub-lethal doses of albendazole induce drug metabolizing enzymes and increase albendazole deactivation in Haemonchus contortus adults

. 2020 Jul 23 ; 51 (1) : 94. [epub] 20200723

UDP-glycosyltransferase family in Haemonchus contortus: Phylogenetic analysis, constitutive expression, sex-differences and resistance-related differences

. 2018 Dec ; 8 (3) : 420-429. [epub] 20180926

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...